Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F4F4X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $42,977
Award facts
- Contract value 100% obligated
- $42,977.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $43K to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen/mL formulation, with an ultimate completion date of January 26, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The contract was executed on January 23, 2026, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (formerly AmerisourceBergen), a major pharmaceutical distribution company that serves as a critical vendor for federal military and healthcare procurement.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999 through December 2026. This comprehensive global pharmaceutical support vehicle enables the delivery of a broad range of brand-name and generic drugs, vaccines, specialty medications, and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The supply of Cosentyx, a biologic immunosuppressant medication used to treat autoimmune conditions, reflects the scope of specialty pharmaceutical products supported through this strategic contract vehicle for the Department of Defense healthcare system.
Quick answers
Who was awarded contract SPE2DR26F4F4X?
SPE2DR26F4F4X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26F4F4X worth?
The government has obligated $42,977 on SPE2DR26F4F4X.
Is contract SPE2DR26F4F4X an order under another contract?
Yes. SPE2DR26F4F4X is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4F4X competed?
The extent of competition for SPE2DR26F4F4X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award